Skip to main content
Equibles

Eukles Asset Management

Position in MRK — Merck & Co., Inc.

CIK 1632553 CINCINNATI, OH
Back to MRK Full portfolio

Position in MRK

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$5,782
+$369 QoQ
Shares Held
45
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3,741
of 3,769 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Eukles Asset Management holds $4,968,554 across 5 Drug Manufacturers - General names. MRK ranks #4 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVO
Novo Nordisk A S
 50,243 $2,408,649
2 JNJ
Johnson & Johnson
 9,471 $2,405,349
3 GILD
Gilead Sciences, Inc.
 1,169 $147,691
4 MRK
Merck & Co., Inc.
This page 		45 $5,782
5 PFE
Pfizer Inc
 45 $1,083

All Filings in MRK

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,782 45
2026-03-31 $5,413 45
2025-12-31 $4,736 45
2025-09-30 $3,776 45
2025-06-30 $3,562 45
2025-03-31 $4,039 45
2024-12-31 $4,476 45
2024-09-30 $5,110 45
2024-06-30 $5,571 45
2024-03-31 $5,937 45
2023-12-31 $4,905 45
2023-09-30 $4,632 45
2023-06-30 $5,192 45
2023-03-31 $4,787 45
2022-12-31 $4,992 45
2022-09-30 $3,875 45
2022-06-30 $4,102 45
2022-03-31 $3,692 45
2021-12-31 $3,448 45
2021-09-30 $3,379 45
2021-06-30 $3,499 45
2021-03-31 $3,469 45

Report a Problem

Category
Description
Email (optional, for follow-up)